Colin Garrioch
Colin is a strategic ally to Canadian start-ups developing natural products and bio-based innovation. With over 15 years developing win-win relationships with companies such as Abbott, Janssen, Novartis, and Pfizer, he brings a powerful understanding of scientific research and business strategy, which makes him a trusted resource in his extensive network.
At NPC, Colin shares his expertise - and those of his NPC colleagues - to provide advice to Canadian start-ups on the ‘next best step’ on their commercialization path. In some cases, that step involves NPC’s Commercialization Programs, which provide up to $350,000 to address key gaps and opportunities. Like all NPC Regional Directors, Colin is known for rolling up his sleeves to help clients design the optimal approach to the Programs – not only to increase their likelihood of receiving funds, but to ensure they strategically address the most critical aspects of their business.
That attention to the ultimate viability and success of his clients is also what makes Colin an invaluable partner to industry and public and private investors who are assessing companies and opportunities. His deep industry experience and critical thinking provide valuable insights into the challenges and growth opportunities for his clients and the industry as a whole.
Colin received his Masters of Science (Human Health and Nutritional Sciences) from the University of Guelph. He is a sought-after member on numerous boards including the Ontario Pharmaceutical Marketing Association (Past President), and Loyalist College: Technology Access Centre for Applied Research for Natural Products & Medical Cannabis (Advisory Board Member).